Patents by Inventor Lindsay Wu

Lindsay Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240131889
    Abstract: An example of an apparatus to transport utility-scale lithium-ion batteries in a racked and operational state. The apparatus includes a base and an isolation platform. In addition, the apparatus includes an isolator mounted on the base to support the isolation platform. The isolator is to dampen forces exerted on the isolation platform from the base. Furthermore, the apparatus includes a rack mounted onto the isolation platform. The rack is to secure a plurality of lithium-ion batteries to store energy at a utility-scale to be provided to a power distribution network. The plurality of lithium-ion batteries is racked in an operational state during transportation.
    Type: Application
    Filed: February 16, 2022
    Publication date: April 25, 2024
    Applicant: NOMAD TRANSPORTABLE POWER SYSTEMS, INC.
    Inventors: Jonathan Edward Bellows, Gregg Richard Noble, Alex David Perkins, Lindsay Edward Gorrill, Paul Brant Coombs, Nan Wu, Jason Jean Martin, Mark Williams Hagedorn
  • Publication number: 20190093140
    Abstract: Enzyme-based systems and methods for synthesizing the NAD precursors NMN and NaMN are disclosed. Such methods and systems utilize a mutated form of phosphoribosylpyrophosphate synthetase (PRS) that is superactive and/or other enzyme or enzyme combinations that are immobilized onto a solid surface. The methods and systems substantially increase the efficiency and yield of NAD precursor synthesis.
    Type: Application
    Filed: June 8, 2016
    Publication date: March 28, 2019
    Inventors: Lindsay Wu, David A. Sinclair, Kyle Meetze
  • Publication number: 20180338991
    Abstract: Disclosed herein are novel compositions and methods for the treatment of age-related diseases, mitochondrial diseases, the improvement of stress resistance, the improvement of resistance to hypoxia and the extension of life span. Also described herein are methods for the identification of agents useful in the foregoing methods. Methods and compositions are provided for the treatment of diseases or disorders associated with mitochondrial dysfunction. The invention relates to methods for treatment and prevention of cancer by administering agents that increase levels of NAD+, such as NAD+ precursors or agents involved in NAD+ biosynthesis.
    Type: Application
    Filed: December 7, 2017
    Publication date: November 29, 2018
    Applicants: President and Fellows of Harvard College, NewSouth Innovations Pty Limited
    Inventors: David A. Sinclair, Ana P. Gomes, Lindsay Wu
  • Publication number: 20180163243
    Abstract: Enzyme-based systems and methods for synthesizing the NAD precursors NMN and NaMN are disclosed. Such methods and systems utilize a mutated form of phosphoribosylpyrophosphate synthetase (PRS) that is superactive and/or other enzyme or enzyme combinations that are immobilized onto a solid surface. The methods and systems substantially increase the efficiency and yield of NAD precursor synthesis.
    Type: Application
    Filed: December 11, 2017
    Publication date: June 14, 2018
    Inventors: Lindsay Wu, David A. Sinclair, Kyle Meetze
  • Publication number: 20180125871
    Abstract: Methods and compositions for preventing or treating peripheral neuropathy, cognitive deficits, inactivity, depression, chemotherapy and/or radiotherapy induced peripheral neuropathy and cognitive deficits, and improving cognitive performance, in a subject in need thereof are disclosed. The disclosed methods include the step of administering to the subject an effective amount of an agent that increases the level of NAD+ in the subject.
    Type: Application
    Filed: April 28, 2016
    Publication date: May 10, 2018
    Inventors: Lindsay Wu, David A. Sinclair
  • Patent number: 9877981
    Abstract: Disclosed herein are novel compositions and methods for the treatment of age-related diseases, mitochondrial diseases, the improvement of stress resistance, the improvement of resistance to hypoxia and the extension of life span. Also described herein are methods for the identification of agents useful in the foregoing methods. Methods and compositions are provided for the treatment of diseases or disorders associated with mitochondrial dysfunction. The invention relates to methods for treatment and prevention of cancer by administering agents that increase levels of NAD+, such as NAD+ precursors or agents involved in NAD+ biosynthesis.
    Type: Grant
    Filed: October 9, 2013
    Date of Patent: January 30, 2018
    Assignees: President and Fellows of Harvard College, NewSouth Innovations Pty Limited
    Inventors: David A. Sinclair, Ana P. Gomes, Lindsay Wu